Cannara Announces Grant of Options and RSUs
Cannara Biotech (OTCQB: LOVFF), a vertically integrated cannabis producer with two mega facilities in Québec totaling over 1,650,000 sq. ft., has announced new incentive awards following its fiscal year-end on August 31, 2025.
The company granted 3,625,000 stock options to employees at an exercise price of $1.44 per share, vesting monthly over three years with a ten-year expiration. Additionally, 145,000 restricted share units (RSUs) were awarded to board members, vesting fully after two years. The announcement comes after five consecutive years of revenue growth in their cannabis operations.
Cannara Biotech (OTCQB: LOVFF), produttore di cannabis verticalmente integrato con due impianti di grandi dimensioni in Québec per un totale di oltre 1.650.000 piedi quadrati, ha annunciato nuove assegnazioni di incentivi dopo la chiusura dell'esercizio fiscale al 31 agosto 2025.
La società ha concesso 3.625.000 opzioni su azioni ai dipendenti a un prezzo di esercizio di $1,44 per azione, con vesting mensile per tre anni e scadenza a dieci anni. Inoltre, sono stati assegnati ai membri del consiglio 145.000 restricted share units (RSU), che matureranno totalmente dopo due anni. L'annuncio segue cinque anni consecutivi di crescita dei ricavi nelle loro attività legate alla cannabis.
Cannara Biotech (OTCQB: LOVFF), un productor de cannabis verticalmente integrado con dos instalaciones de gran tamaño en Québec que suman más de 1.650.000 pies cuadrados, ha anunciado nuevas concesiones de incentivos tras el cierre del ejercicio fiscal al 31 de agosto de 2025.
La compañía otorgó 3.625.000 opciones sobre acciones a empleados con un precio de ejercicio de $1,44 por acción, que se consolidan mensualmente durante tres años y expiran a los diez años. Además, se concedieron 145.000 restricted share units (RSU) a miembros del consejo, que se harán efectivas por completo después de dos años. El anuncio se produce tras cinco años consecutivos de crecimiento de ingresos en sus operaciones de cannabis.
Cannara Biotech (OTCQB: LOVFF)는 퀘벡에 총 1,650,000 평방피트가 넘는 대형 시설 두 곳을 보유한 수직 통합형 대마(칸나비스) 생산업체로, 2025년 8월 31일 회계연도 종료에 따라 새로운 인센티브 수여를 발표했습니다.
회사는 직원들에게 행사 가격 주당 $1.44로 3,625,000주의 스톡옵션을 부여했으며, 이는 3년에 걸쳐 월별로 베스팅되고 만기는 10년입니다. 또한 이사회 구성원에게는 145,000개의 제한주(RSU)가 부여되어 2년 후 전액 베스팅됩니다. 이번 발표는 칸나비스 사업에서 5년 연속 매출 성장 이후에 나왔습니다.
Cannara Biotech (OTCQB: LOVFF), producteur de cannabis intégré verticalement disposant de deux méga-installations au Québec totalisant plus de 1 650 000 pieds carrés, a annoncé de nouvelles attributions d'incitations après la clôture de l'exercice au 31 août 2025.
La société a octroyé 3 625 000 options d'achat d'actions aux employés à un prix d'exercice de 1,44 $ par action, se consolidant mensuellement sur trois ans et expirant au bout de dix ans. De plus, 145 000 restricted share units (RSU) ont été attribuées aux administrateurs, qui seront entièrement acquises après deux ans. Cette annonce intervient après cinq années consécutives de croissance des revenus dans leurs activités liées au cannabis.
Cannara Biotech (OTCQB: LOVFF), ein vertikal integrierter Cannabisproduzent mit zwei Mega-Anlagen in Québec mit insgesamt über 1.650.000 Quadratfuß, hat nach Abschluss des Geschäftsjahres am 31. August 2025 neue Anreizzuteilungen angekündigt.
Das Unternehmen gewährte Mitarbeitern 3.625.000 Aktienoptionen zu einem Ausübungspreis von $1,44 pro Aktie, die monatlich über drei Jahre vesten und eine Laufzeit von zehn Jahren haben. Zusätzlich wurden dem Vorstand 145.000 Restricted Share Units (RSUs) zugesprochen, die nach zwei Jahren vollständig vesten. Die Ankündigung erfolgt nach fünf aufeinanderfolgenden Jahren mit Umsatzwachstum im Cannabisgeschäft.
- Five consecutive years of year-over-year revenue growth
- Comprehensive employee and director incentive program implemented
- Large-scale operations with two mega facilities totaling 1,650,000 sq. ft.
- Potential dilution from 3,770,000 new shares through options and RSUs
MONTREAL, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that its board of directors has approved the grant of incentive awards under the Company’s stock option plan (the “Stock Option Plan”), and restricted share unit compensation plan (the “RSU Plan”) (collectively, the “Incentive Plans”).
The awards were granted aligning with the completion of the Company’s fiscal year-end on August 31, 2025, which marked five consecutive years of commercial operations and year-over-year revenue growth since launching its cannabis business.
In accordance with and subject to the terms of the Incentive Plans and the applicable requirements of the TSX Venture Exchange (the “TSXV”), the Company has granted, effective August 28, 2025:
- 3,625,000 stock options to certain employees of the Company. Each stock option is exercisable into one common share of the Company at an exercise price of
$1.44 per share, will vest in equal monthly installments over a period of three (3) years, and will expire ten (10) years from the date of grant. - 145,000 restricted share units (RSUs) to members of the board of directors. Each RSU entitles the holder to receive one common share of the Company without additional consideration and will vest in full on the second anniversary of the date of grant.
The grants are subject to the terms of the Incentive Plans and the applicable requirements of the TSXV.
CONTACT
| Nicholas Sosiak, CPA, CA Chief Financial Officer nick@cannara.ca | Zohar Krivorot President & Chief Executive Officer zohar@cannara.ca |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
ABOUT CANNARA
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.
FAQ
How many stock options did Cannara Biotech (LOVFF) grant in September 2025?
What is the vesting period for Cannara Biotech's 2025 RSU grants?
What is the size of Cannara Biotech's production facilities?
How long has Cannara Biotech been showing revenue growth?
